# The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)

> **NCT00943852** · PHASE1 · COMPLETED · sponsor: **Organon and Co** · enrollment: 13 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** losartan potassium
- **DRUG:** Comparator: isosorbide mononitrate (ISMN)
- **DRUG:** Comparator: losartan + ISMN
- **DRUG:** Comparator: losartan + ISMN
- **DRUG:** Comparator: Placebo

## Key facts

- **NCT ID:** NCT00943852
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00943852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00943852, "The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00943852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*